A 14-year-old male with asymptomatic proteinuria and hearing loss

American Journal of Kidney Diseases

Volumn 41, Issue 1, 2003, Pages 259-264

  Nasr, Samih H ^a,b   Corey, Howard ^a,b   Shanske, Sara ^a,b   Pancrudo, Jacklyn ^a,b   Kaufmann, Petra ^a,b   Markowitz, Glen S ^a,b   DiMauro, Salvatore ^a,b   D'Agati, Vivette D ^a,b  

^a Howard Hughes Medical Institute   (United States)

^b Atlantic Health   (United States)

Author keywords

Mitochondrial cytopathy; Mitochondriopathy

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; EDEMA; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HEARING AID; HEARING LOSS; HEART ATRIUM SEPTUM DEFECT; HEMATURIA; HUMAN; KIDNEY BIOPSY; LABORATORY TEST; MALE; OLIGURIA; PHYSICAL EXAMINATION; PROTEINURIA; VOMITING;

EID: 0037223893     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50068     Document Type: Article

References (20)

1. Chen A, Francis M, Ni L, et al: Phenotypic manifestations of branchio-oto-renal syndrome. Am J Med Genet 58:365-370, 1995
2. DiMauro S, Schon EA: Mitochondrial DNA mutations in human disease. Am J Med Genet 106:18-26, 2001
3. Yorifuji T, Kawai M, Momoi T, et al: Nephropathy and growth hormone deficiency in a patient with mitochondrial tRNA(Leu(UUR)) mutation. J Med Genet 33:621-622, 1996
4. Eviatar L, Shanske S, Gauthier B, et al: Kearns-Sayre syndrome presenting as renal tubular acidosis. Neurology 40:1761-1763, 1990
5. Mochizuki H, Joh K, Kawame H, et al: Mitochondrial encephalomyopathies preceded by de-Toni-Debré-Fanconi syndrome or focal segmental glomerulosclerosis. Clin Nephrol 46:347-352, 1996
6. Rötig A, Lehnert A, Rustin P, et al: Kidney involvement in mitochondrial disorders. Adv Nephrol Necker Hosp 24:367-378, 1995
7. Niaudet P, Rötig A: Renal involvement in mitochondrial cytopathies. Pediatr Nephrol 10:368-373, 1996
8. McShane MA, Hammans SR, Sweeney M, et al: Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 48:39-42, 1991
9. Zupanc ML, Morgan CT, Shanske S, Langman CB, Ciafaloni E, DiMauro S: Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol 29:680-683, 1991
10. Zeviani M, Nonaka I, Bonilla E. et al: Fatal infantile mitochondrial myopathy and renal dysfunction caused by cytochrome c oxidase deficiency: Immunological studies in a new patient. Ann Neurol 17:414-417, 1985
11. Birch-Machin MA, Shepherd IM, Watmough NJ, et al: Fatal lactic acidosis in infancy with a defect of complex III of the respiratory chain, Pediatr Res 25:553-559, 1989
12. Minchom PE, Dormer RL, Hughes IA, et al: Fatal infantile mitochondrial myopathy due to cytochrome c oxidase deficiency. J Neurol Sci 60:453-463, 1983
13. Müller-Höcker J, Pongratz D, Deufel T, Trijbels JMF, Endres W, Hübner G: Fatal lipid storage myopathy with deficiency of cytochrome-c-oxidase and carnitine. A contribution to the combined cytochemical-finestructural identification of cytochrome-c-oxidase in longterm frozen muscle. Virchows Arch A Pathol Anat Histopathol 399:11-23, 1983
14. Szabolcs MJ, Seije R, Shanske S, Bonilla E, DiMauro S, D'Agati V: Mitochondrial DNA deletion: A cause of chronic tubulointerstitial nephropathy. Kidney Int 45:1388-1396, 1994
15. Rötig A, Goutières F, Niaudet P, et al: Deletion of mitochondrial DNA in patient with chronic tubulointerstitial nephritis. J Pediatr 126:597-601, 1995
16. Donaldson MDC, Warner AA, Trompeter R, Haycock GB, Chantler C: Familial juvenile nephronophthisis, Jeune's syndrome, and associated disorders. Arch Dis Child 60:426-434, 1985
17. Tzen CY, Tsai JD, Wu TY, et al: Tubulointerstitial nephritis associated with a novel mitochondrial point mutation. Kidney Int 59:846-854, 2001
18. Hotta O, Inoue CN, Miyabayashi S, Furuta T, Takeuchi A, Taguma Y: Clinical and pathologic features of focal segmental glomeruosclerosis with mitochondrial tRNALeu(UUR) gene mutation. Kidney Int 59:1236-1243, 2001
19. Kurogouchi F, Oguchi T, Mawatari E, et al: A case of mitochondrial cytopathy with a typical point mutation for MELAS, presenting with severe focal-segmental glomerulosclerosis as main clinical manifestation. Am J Nephrol 18:551-556, 1998
20. Doleris LM, Hill GS, Chedin P, et al: Focal segmental glomerulosclerosis associated with mitochondrial cytopathy. Kidney Int 58:1851-1858, 2000